Saskatchewan Health Authority

New study reveals four critical barriers to building healthier Canadian cities

Retrieved on: 
Wednesday, February 14, 2024

The 15-minute city is all about accessibility, time efficiency and expanding options for everyone, not just the most well-off.

Key Points: 
  • The 15-minute city is all about accessibility, time efficiency and expanding options for everyone, not just the most well-off.
  • Achieving this goal, and designing healthier spaces, begins with a comprehensive understanding of how urban environments impact our health and well-being — along with a realistic look at the current barriers to healthier urban design.

Designing better spaces

  • Neighbourhoods with accessible public and community spaces and social events have been shown to improve mental health, increase happiness, and offer a sense of belonging and community.
  • At the same time, readily accessible grocery stores, community gardens and farmers’ markets have been shown to enhance mental, social and physical health.
  • This is where urban planning comes in as municipal policy-makers develop and implement policies, which can alter the structure, use and regulations of public spaces in cities.

Day-to-day challenges

  • While the importance of physical and mental health was widely acknowledged, a glaring gap exists in the recognition of the social dimension of health.
  • Administrative roadblocks, such as a lack of co-ordination between, and within, provincial and municipal governments, can prevent access to crucial data needed for policy making.
  • Meanwhile, technical barriers — including the use of jargon and overly-technical language by the academic community — can interfere with the accessibility of academic literature.
  • This lack of co-ordination among different branches and divisions within a municipality can result in missed opportunities for collaboration.
  • Differences in the use of terminology can exacerbate the problem, causing confusion and impeding cross-sectoral work.
  • Conflicts between the objectives of various divisions, such as those between active transportation planners and traffic engineers, underscore the challenges posed by siloed governance.
  • 4 – Political ideologies get in the way Beyond bureaucratic challenges, differing political ideologies present a formidable barrier.

Overcoming these barriers

  • The journey towards creating healthier and more equitable cities is riddled with challenges.
  • From a lack of shared understanding, to inaccessible evidence, fragmented governance and legal limitations of municipalities and differing political ideologies, the barriers are multifaceted.
  • Akram Mahani holds funding from SHRF (Saskatchewan Health Research Foundation) and CIHR (Canadian Institutes of Health Research).
  • Nazeem Muhajarine receives funding from the Canadian Institutes of Health Research and the Social Sciences and Humanities Research Council of Canada.

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Retrieved on: 
Tuesday, January 9, 2024

ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced that it has strengthened its leadership team with the appointment of Scott Livingstone to the role of Vice President of Clinical Research with its wholly owned subsidiary, ZYUS Life Sciences Inc.

Key Points: 
  • ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced that it has strengthened its leadership team with the appointment of Scott Livingstone to the role of Vice President of Clinical Research with its wholly owned subsidiary, ZYUS Life Sciences Inc.
  • "We are pleased to announce Scott Livingstone's appointment to VP of Clinical Research with ZYUS Life Sciences Inc.," said Brent Zettl, President and CEO of the Company.
  • "His leadership and experience will be instrumental in guiding our clinical research initiatives, particularly in overseeing the Phase 2 Clinical Trial for Trichomylin softgel capsules.
  • This strategic addition to our team reaffirms ZYUS’ commitment to the development of evidence-based solutions to address unmet patient needs.”
    “I'm honored to lead ZYUS’ clinical research initiatives, driven by a profound dedication to improving lives through innovative discoveries,” said Mr. Livingstone.

More than 75% of Canadians had immunity to SARS-CoV-2 due to infection by March 2023

Retrieved on: 
Monday, August 14, 2023

Today, the COVID-19 Immunity Task Force (CITF) published the most comprehensive peer-reviewed analysis of pan-Canadian seroprevalence estimates in CMAJ (Canadian Medical Association Journal) .

Key Points: 
  • Today, the COVID-19 Immunity Task Force (CITF) published the most comprehensive peer-reviewed analysis of pan-Canadian seroprevalence estimates in CMAJ (Canadian Medical Association Journal) .
  • Three time periods were analyzed: pre-vaccination (March 2020 to November 2020); vaccine roll-out (December 2020 to November 2021); and the Omicron waves (December 2021 to March 2023).
  • The low infection rates in Canada before Omicron were observed in other high-income countries in Europe and North America as well.
  • “By March 2023, roughly 80% of adults aged 18-25 had evidence of a previous infection.

Extendicare Announces 2022 Fourth Quarter and Year End Results

Retrieved on: 
Thursday, March 2, 2023

MARKHAM, Ontario, March 02, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2022.

Key Points: 
  • MARKHAM, Ontario, March 02, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2022.
  • Average long-term care (“LTC”) occupancy improved by 100 bps to 94.5%(1) from Q3 2022 despite persistent COVID-19 outbreaks, which drove elevated costs.
  • Home health care average daily volumes (“ADV”) up 2.0% from Q3 2022; 90 bps improvement in NOI margins from Q3 2022 excluding net COVID costs.
  • Governments continue to provide support for elevated pandemic costs, although the extent and timing of funding lagged, putting pressure on our financial results in the quarter.

Extendicare Announces 2022 Third Quarter Results

Retrieved on: 
Thursday, November 10, 2022

MARKHAM, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) today reported results for the three and nine months ended September 30, 2022.

Key Points: 
  • MARKHAM, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) today reported results for the three and nine months ended September 30, 2022.
  • The pandemic continues to cause volatility in our results, with ongoing mismatches between costs and funding.
  • In Q3 2022, pandemic related spending increased by $0.4 million to $22.5 million from Q2 2022 and was largely offset by provincial funding.
  • Q3 2022 included $1.1 million related to the recovery of 2021 COVID costs, resulting in net unfunded COVID-19 costs from continuing operations of $0.5 million in the quarter.

Boston Cell Standards Launches Consortium for Analytic Standardization in Immunohistochemistry (CASI)

Retrieved on: 
Tuesday, March 8, 2022

Boston Cell Standards, a company dedicated to ensuring that cancer patients receive accurate diagnosis and treatment, announced that it launched the Consortium for Analytic Standardization in Immunohistochemistry (CASI).

Key Points: 
  • Boston Cell Standards, a company dedicated to ensuring that cancer patients receive accurate diagnosis and treatment, announced that it launched the Consortium for Analytic Standardization in Immunohistochemistry (CASI).
  • It holds the entire field of pathology back, said Dr. Steve Bogen, CEO of Boston Cell Standards, a board-certified clinical pathologist.
  • Boston Cell Standards invented the first and only IHC reference materials, including calibrators for IHC standardization and controls for daily verification of IHC assay accuracy.
  • Boston Cell Standards is the first and only company to develop and manufacture quantitative reference materials in the immunohistochemistry industry.

Sienna Senior Living Announces New Acquisitions and $75 Million Bought Deal Public Offering of Common Shares

Retrieved on: 
Monday, February 28, 2022

MARKHAM, Ontario, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX:SIA) provided an update on the Company's acquisition activity and announced today the launch of a $75 million equity offering, on a bought deal basis.

Key Points: 
  • Sienna intends to act as manager of the property and earn a management fee.
  • If the Over-Allotment Option is exercised in full, the gross proceeds to the Company will be approximately $86 million.
  • The Company intends to use the net proceeds of the Offering and any Over-Allotment Option to partially fund the Acquisitions and pay the Company's expenses of the Acquisitions.
  • Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors' living options, including independent living, assisted living, long-term care, and specialized programs and services.

Extendicare Announces Agreement to Sell Esprit Retirement Communities

Retrieved on: 
Thursday, February 3, 2022

We are pleased with the value we will realize on our retirement living investment.

Key Points: 
  • We are pleased with the value we will realize on our retirement living investment.
  • We extend our appreciation to the staff of our Esprit communities who demonstrated a steadfast commitment to providing outstanding care throughout the pandemic, added Guerriere.
  • CBRE Capital Markets is acting as financial advisor to Extendicare and Bennett Jones LLP is acting as legal advisor to Extendicare in connection with the Transaction.
  • Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, Esprit Lifestyle, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.

Sienna Senior Living Announces Significant Expansion of Ontario Retirement Portfolio and Entry Into Saskatchewan Retirement Market Through the Formation of a Strategic Joint Venture

Retrieved on: 
Thursday, February 3, 2022

In addition, the Portfolio offers a suite of extensive and sought-after amenities and services, such as movie theatres, fitness centres and spas.

Key Points: 
  • In addition, the Portfolio offers a suite of extensive and sought-after amenities and services, such as movie theatres, fitness centres and spas.
  • The Acquisition represents a rare opportunity for Sienna to enter the Saskatchewan seniors living market with four desirable retirement residences, achieving immediate scale and providing a platform for future growth.
  • Saskatchewan's growing retirement-aged population, solid market fundamentals, workforce productivity and influx of capital investment all make this an attractive new market.
  • Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors' living options, including independent living, assisted living, long-term care, and specialized programs and services.

B.C.'s Vitacore Industries Announces Production Facility And PPE Recycling Project In Saskatchewan

Retrieved on: 
Tuesday, November 16, 2021

VANCOUVER, BC, Nov. 16, 2021 /CNW/ - Vitacore Industries Inc. has announced it will be opening a full-scale production facility in Saskatchewan for the manufacturing of medical equipment and PPE in 2022.

Key Points: 
  • VANCOUVER, BC, Nov. 16, 2021 /CNW/ - Vitacore Industries Inc. has announced it will be opening a full-scale production facility in Saskatchewan for the manufacturing of medical equipment and PPE in 2022.
  • The company will also expand its end-to-end recycling program for single use masks and respirators to the region in a pilot program with the Saskatchewan Health Authority.
  • The first of its kind in Canada, Vitacore's recycling program aims to reduce the pollution in Canada's landfills and create a more sustainable future.
  • Vitacore Industries is driven by innovation to provide Canadian healthcare professionals and families with critical personal protective equipment.